Lazard Asset Management’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $601M | Sell |
1,222,057
-12,377
| -1% | -$6.72M | 0.99% | 18 |
|
|
2025
Q4 | $715M | Sell |
1,234,434
-348,438
| -22% | -$197M | 1.21% | 17 |
|
|
2025
Q3 | $768M | Sell |
1,582,872
-17,742
| -1% | -$8.26M | 1.03% | 18 |
|
|
2025
Q2 | $649M | Buy |
1,600,614
+42,767
| +3% | +$17.9M | 0.89% | 23 |
|
|
2025
Q1 | $775M | Buy |
1,557,847
+65,732
| +4% | +$35.6M | 1.19% | 10 |
|
|
2024
Q4 | $776M | Sell |
1,492,115
-298,040
| -17% | -$164M | 1.14% | 15 |
|
|
2024
Q3 | $1.11B | Sell |
1,790,155
-16,900
| -0.9% | -$10M | 1.48% | 11 |
|
|
2024
Q2 | $999M | Sell |
1,807,055
-33,397
| -2% | -$19.1M | 1.25% | 14 |
|
|
2024
Q1 | $1.07B | Sell |
1,840,452
-37,250
| -2% | -$20.9M | 1.3% | 13 |
|
|
2023
Q4 | $997M | Sell |
1,877,702
-34,255
| -2% | -$16.6M | 1.26% | 11 |
|
|
2023
Q3 | $968M | Sell |
1,911,957
-49,969
| -3% | -$26.6M | 1.32% | 11 |
|
|
2023
Q2 | $1.02B | Buy |
1,961,926
+39,591
| +2% | +$21.4M | 1.26% | 13 |
|
|
2023
Q1 | $1.11B | Buy |
1,922,335
+46,298
| +2% | +$26.1M | 1.45% | 9 |
|
|
2022
Q4 | $1.03B | Sell |
1,876,037
-2,947
| -0.2% | -$1.56M | 1.42% | 11 |
|
|
2022
Q3 | $953M | Sell |
1,878,984
-34,465
| -2% | -$19.3M | 1.39% | 12 |
|
|
2022
Q2 | $1.04B | Sell |
1,913,449
-50,954
| -3% | -$28M | 1.41% | 11 |
|
|
2022
Q1 | $1.16B | Sell |
1,964,403
-92,209
| -4% | -$53M | 1.34% | 12 |
|
|
2021
Q4 | $1.37B | Sell |
2,056,612
-30,274
| -1% | -$18.9M | 1.46% | 11 |
|
|
2021
Q3 | $1.19B | Sell |
2,086,886
-38,810
| -2% | -$21.3M | 1.35% | 12 |
|
|
2021
Q2 | $1.07B | Buy |
2,125,696
+158,778
| +8% | +$74.9M | 1.2% | 14 |
|
|
2021
Q1 | $898M | Sell |
1,966,918
-13,150
| -0.7% | -$6.28M | 1.09% | 17 |
|
|
2020
Q4 | $922M | Buy |
1,980,068
+19,391
| +1% | +$9.09M | 1.17% | 16 |
|
|
2020
Q3 | $866M | Sell |
1,960,677
-123,337
| -6% | -$51M | 1.22% | 18 |
|
|
2020
Q2 | $755M | Buy |
2,084,014
+300,277
| +17% | +$101M | 1.16% | 18 |
|
|
2020
Q1 | $506M | Sell |
1,783,737
-2,941
| -0.2% | -$927K | 0.93% | 25 |
|
|
2019
Q4 | $580M | Buy |
1,786,678
+50,694
| +3% | +$15.4M | 0.83% | 28 |
|
|
2019
Q3 | $506M | Sell |
1,735,984
-187,714
| -10% | -$53.8M | 0.83% | 27 |
|
|
2019
Q2 | $565M | Sell |
1,923,698
-347,706
| -15% | -$95.8M | 0.92% | 24 |
|
|
2019
Q1 | $622M | Buy |
2,271,404
+73,846
| +3% | +$18.4M | 1.02% | 23 |
|
|
2018
Q4 | $492M | Buy |
2,197,558
+282,573
| +15% | +$66.3M | 0.91% | 27 |
|
|
2018
Q3 | $467M | Buy |
1,914,985
+455,947
| +31% | +$105M | 0.76% | 36 |
|
|
2018
Q2 | $302M | Buy |
1,459,038
+21,568
| +2% | +$4.58M | 0.53% | 56 |
|
|
2018
Q1 | $297M | Buy |
1,437,470
+124,631
| +9% | +$26.2M | 0.51% | 60 |
|
|
2017
Q4 | $249M | Buy |
1,312,839
+154,794
| +13% | +$29.7M | 0.43% | 63 |
|
|
2017
Q3 | $219M | Buy |
1,158,045
+6,789
| +0.6% | +$1.23M | 0.4% | 61 |
|
|
2017
Q2 | $201M | Buy |
1,151,256
+61,943
| +6% | +$10.4M | 0.38% | 64 |
|
|
2017
Q1 | $167M | Sell |
1,089,313
-1,577
| -0.1% | -$241K | 0.32% | 73 |
|
|
2016
Q4 | $154M | Sell |
1,090,890
-344,826
| -24% | -$50.8M | 0.31% | 74 |
|
|
2016
Q3 | $228M | Sell |
1,435,716
-80,178
| -5% | -$12.4M | 0.45% | 60 |
|
|
2016
Q2 | $224M | Sell |
1,515,894
-272,116
| -15% | -$40.2M | 0.47% | 64 |
|
|
2016
Q1 | $253M | Buy |
1,788,010
+283,873
| +19% | +$38M | 0.55% | 54 |
|
|
2015
Q4 | $213M | Buy |
1,504,137
+452,609
| +43% | +$60.4M | 0.49% | 57 |
|
|
2015
Q3 | $129M | Buy |
1,051,528
+320,800
| +44% | +$41.8M | 0.31% | 85 |
|
|
2015
Q2 | $94.8M | Buy |
730,728
+229,725
| +46% | +$29.9M | 0.2% | 122 |
|
|
2015
Q1 | $67.3M | Sell |
501,003
-80,569
| -14% | -$10.4M | 0.15% | 144 |
|
|
2014
Q4 | $72.9M | Buy |
581,572
+153,014
| +36% | +$18.6M | 0.16% | 137 |
|
|
2014
Q3 | $52.2M | Buy |
428,558
+51,952
| +14% | +$6.32M | 0.11% | 161 |
|
|
2014
Q2 | $44.4M | Buy |
376,606
+14,295
| +4% | +$1.68M | 0.09% | 181 |
|
|
2014
Q1 | $43.6M | Buy |
362,311
+349,791
| +2,794% | +$41.6M | 0.1% | 177 |
|
|
2013
Q4 | $1.39M | Hold |
12,520
| – | – | ﹤0.01% | 676 |
|
|
2013
Q3 | $1.15M | Sell |
12,520
-500
| -4% | -$45.2K | ﹤0.01% | 669 |
|
|
2013
Q2 | $1.1M | Buy |
+13,020
| New | +$1.08M | ﹤0.01% | 691 |
|
Other funds holding TMO
VCM
Lazard Asset Management's TMO Position: Q1 2026 in Review
Lazard Asset Management reduced its Thermo Fisher Scientific (TMO) stake by 1% in Q1 2026, selling an estimated $6.72M and leaving 1,222,057 shares worth $601M. The position accounts for 0.99% of the portfolio, ranked #18.
Lazard Asset Management first reported a position in TMO in Q2 2013 and has held it in 52 quarters since. The position peaked at $1.37B in Q4 2021. 2,587 funds tracked by Wall St. Rank hold TMO as of Q1 2026.
- Lazard Asset Management held 1,222,057 shares of Thermo Fisher Scientific worth $601M as of Q1 2026.
- Lazard Asset Management sold 12,377 Thermo Fisher Scientific shares in Q1 2026, an estimated $6.72M.
- Thermo Fisher Scientific made up 0.99% of Lazard Asset Management's portfolio in Q1 2026, its #18 holding.
- Lazard Asset Management first reported a position in Thermo Fisher Scientific in Q2 2013 and has held it in 52 quarters since.
- Lazard Asset Management's Thermo Fisher Scientific position peaked at $1.37B in Q4 2021.
- 2,587 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q1 2026.
Based on Lazard Asset Management's 13F filing for Q1 2026, filed 15 May 2026.